Arilvax vaccine powder and solvent for suspension for injection 0.5ml vials
Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Yellow fever virus strain 17D
Available from:
Novartis Vaccines and Diagnostics Ltd
ATC code:
J07BL01
INN (International Name):
Yellow fever virus strain 17D
Pharmaceutical form:
Powder and solvent for suspension for injection
Administration route:
Subcutaneous
Class:
No Controlled Drug Status
Prescription type:
Valid as a prescribable product
Product summary:
BNF: 14040000
